ISIN
CH1243598427
Ticker
SDZ
Sector
Sub-Industry
Country
Switzerland
Year Founded
1886
Sandoz operates in the attractive and growing global off-patent medicines market, which benefits from a growing and aging population, higher rates of chronic disease, increasing market adoption as healthcare systems and payors seek to reduce the cost of medicines, and a consistent supply of upcoming loss of exclusivities (LoEs) as patents for originator products expire. Together, these drivers are expected to support long-term growth in volumes that will more than offset anticipated erosion in price.
Worldwide
Date | Trading entity / Person | Association | Trade type | Volume |
---|---|---|---|---|
30.04.2024 | None | Non-Executive member | Buy | CHF 130,000.00 |
30.04.2024 | None | Non-Executive member | Buy | CHF 115,000.00 |
30.04.2024 | None | Non-Executive member | Buy | CHF 62,500.00 |
30.04.2024 | None | Non-Executive member | Buy | CHF 54,000.00 |
17.11.2023 | None | Non-Executive member | Buy | CHF 988,797.00 |
17.11.2023 | None | Non-Executive member | Buy | CHF 200,493.50 |
10.11.2023 | None | Non-Executive member | Buy | CHF 84,583.00 |
10.11.2023 | None | Non-Executive member | Buy | CHF 72,917.00 |
10.11.2023 | None | Non-Executive member | Buy | CHF 13,417.00 |
25.10.2023 | None | Executive member | Buy | CHF 486,590.00 |
CH1243598427
549300X7ELPSP81ATF17
Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.